medtech

Rna Diagnostics

A Real Time cancer therapy guidance tool

  • Toronto, Ontario
  • MedTech
  • Invested in 2018

The Story

Rna Diagnostics is dedicated to improving the management of cancer treatments. The RNA Disruption Assay will provide physicians with an evaluation of how patients are responding to cancer treatments. In real time. If the cancer drugs are working, the physician and patient can continue with confidence. If the cancer drugs are not working well enough, physicians may consider alternate treatments. For patients, this means avoiding harmful side effects and an opportunity to improve outcomes. This is personalized medicine.

Rna Diagnostics is a cancer diagnostics company building  a platform of predictive biomarkers to improve the lives of cancer patients. RDA has the potential to substantially improve cancer treatment for patients while reducing costs for healthcare systems.

Jeremy Bridge-Cook

CEo, Rna Diagnostics

About

  • iGan Partners is a venture capital firm investing in emerging early-stage tech companies with a focus on Digital Health and B2B SaaS.

Copyright © 2018 iGan Partners